Serum Müllerian Inhibiting Substance/Anti-Müllerian Hormone levels in patients with adult granulosa cell tumors directly correlate with aggregate tumor mass as determined by pathology or radiology

Gynecologic Oncology

Volumn 114, Issue 1, 2009, Pages 57-60

  Chang, Henry L ^a   Pahlavan, Nima ^a   Halpern, Elkan F ^a   MacLaughlin, David T ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adult granulosa cell tumor; Anti M llerian hormone; M llerian Inhibiting Substance; Ovarian sex cord stromal tumor

Indexed keywords

MUELLERIAN INHIBITING FACTOR;

ADULT; AGED; ARTICLE; CANCER SIZE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GRANULOSA CELL TUMOR; GYNECOLOGIC SURGERY; HISTOPATHOLOGY; HORMONE BLOOD LEVEL; HUMAN; HUMAN TISSUE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; RADIODIAGNOSIS; RETROSPECTIVE STUDY;

ADULT; ANTI-MULLERIAN HORMONE; FEMALE; GRANULOSA CELL TUMOR; HUMANS; NEOPLASM STAGING; OVARIAN NEOPLASMS; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES;

EID: 67349115264     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2009.02.023     Document Type: Article

References (15)

1. Schumer S.T., and Cannistra S.A. Granulosa cell tumor of the ovary. J. Clin. Oncol. 21 (2003) 1180-1189
2. Teixeira J., Maheswaran S., and Donahoe P.K. Müllerian inhibiting substance: an instructive developmental hormone with diagnostic and possible therapeutic applications. Endocr. Rev. 22 (2001) 657-674
3. La Marca A., and Volpe A. The anti-Müllerian hormone and ovarian cancer. Hum. Reprod. Update. 13 (2007) 265-273
4. Hudson P.L., Dougas I., Donahoe P.K., Cate R.L., Epstein J., Pepinsky R.B., et al. An immunoassay to detect human Müllerian inhibiting substance in males and females during normal development. J. Clin. Endocrinol. Metab. 70 (1990) 16-22
5. Josso N., Legeai L., Forest M.G., Chaussain J.L., and Brauner R. An enzyme linked immunoassay for anti-Müllerian hormone: a new tool for the evaluation of testicular function in infants and children. J. Clin. Endocrinol. Metab. 70 (1990) 23-27
6. Baker M.L., Metcalfe S.A., and Hutson J.M. Serum levels of Müllerian inhibiting substance in boys from birth to 18 years, as determine by enzyme immunoassay. J. Clin. Endocrinol. Metab. 70 (1990) 11-15
7. Rey R.A., Lhommé C., Marcillac I., Lahlou N., Duvillard P., Josso N., et al. Antimüllerian hormone as a serum marker of granulosa cell tumors of the ovary: comparative study with serum alpha-inhibin and estradiol. Am. J. Obstet. Gynecol. 174 (1996) 958-965
8. Lee M.M., Donahoe P.K., Hasegawa T., Silverman B., Crist G.B., Best S., et al. Müllerian inhibiting substance in humans: normal levels from infancy to adulthood. J. Clin. Endocrinol. Metab. 81 (1996) 571-576
9. Cook C.L., Siow Y., Taylor S., and Fallat M.E. Serum Müllerian-inhibiting substance levels during normal menstrual cycles. Fertil. Steril. 73 (2000) 759-861
10. Gustafson M.L., Lee M.M., Scully R.E., Moncure A.C., Hirakawa T., Goodman A., et al. Müllerian inhibiting substance as a marker for ovarian sex-cord tumor. N. Engl. J. Med. 326 (1992) 466-471
11. Lane A.H., Lee M.M., Fuller A.F., Kehas D.J., Donahoe P.K., and MacLaughlin D.T. Diagnostic utility of Müllerian inhibiting substance determination in patients with primary and recurrent granulosa cell tumors. Gynecol. Oncol. 73 (1999) 51-55
12. Rey R., Sabourin J.C., Venara M., Long W.Q., Jaubert F., Zeller W.P., et al. Anti-Müllerian hormone is a specific marker of Sertoli- and granulosa-cell origin in gonadal tumors. Hum. Pathol. 31 (2000) 1202-1208
13. Vigier B., Picard J.Y., Tran D., Legeai L., and Josso N. Production of anti-Müllerian hormone: another homology between Sertoli and granulosa cells. Endocrinology 114 (1984) 1315-1320
14. Takahashi M., Hayashi M., Manganaro T.F., and Donahoe P.K. The ontogeny of Müllerian inhibiting substance in granulosa cells of the bovine ovarian follicle. Biol. Reprod. 35 (1986) 447-453
15. Anttonen M., Unkila-Kallio L., Leminen A., Butzow R., and Heikinheimo M. High GATA-4 expression associates with aggressive behavior, whereas low anti-Müllerian hormone expression associates with growth potential of ovarian granulosa cell tumors. J. Clin. Endocrinol. Metab. 90 (2005) 6529-6535